After safety signal in Moderna's trial forced vaccinemaker to end study
FDA disclosed today that enrollment of young children is now
"on hold for all clinical studies of RSV vaccine candidates under U.S. IND"
https://www.fda.gov/media/184301/download
FDA disclosed today that enrollment of young children is now
"on hold for all clinical studies of RSV vaccine candidates under U.S. IND"
https://www.fda.gov/media/184301/download
Comments
Comes after Moderna's trial found of RSV for youngest kids
"severe illness was 26.3% in the vaccine groups compared with 8.3% in the placebo"
https://www.fda.gov/media/184301/download
Stems from "observation of vaccine-associated enhanced respiratory disease (VAERD), including two toddler deaths" in 1960s
https://www.fda.gov/media/184301/download